Mic Capital Management Uk LLP Recursion Pharmaceuticals, Inc. Transaction History
Mic Capital Management Uk LLP
- $391 Million
- Q3 2025
A detailed history of Mic Capital Management Uk LLP transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mic Capital Management Uk LLP holds 9,644,032 shares of RXRX stock, worth $39.9 Million. This represents 12.03% of its overall portfolio holdings.
Number of Shares
9,644,032
Previous 9,644,032
-0.0%
Holding current value
$39.9 Million
Previous $48.8 Million
3.56%
% of portfolio
12.03%
Previous 12.97%
Shares
4 transactions
Others Institutions Holding RXRX
# of Institutions
362Shares Held
301MCall Options Held
7.71MPut Options Held
4.85M-
Vanguard Group Inc Valley Forge, PA39.8MShares$165 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.5MShares$139 Million1.15% of portfolio
-
Baillie Gifford & CO24MShares$99.3 Million0.09% of portfolio
-
State Street Corp Boston, MA18.3MShares$75.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$71.7 Million0.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $747M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...